Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Optimum Imaging Diagnostics
AddedFeb 18, 2024
UpdatedJun 18, 2026
Optimum Imaging Diagnostics

Optimum Imaging Diagnostics

Angel

OIDx develops highly sensitive, rapid medical diagnostic tests, ensuring faster, reliable results for emerging diseases.

HQ
Scarborough, ME, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Optimum Imaging Diagnostics (OIDx), founded in Scarborough, ME, specializes in developing highly sensitive, rapid medical diagnostic tests. Their core mission is to provide healthcare professionals with reliable and fast diagnostic solutions to manage patient health effectively. OIDx focuses on emerging diseases, ensuring that their tests meet the most rigorous industry standards. Their flagship product includes a 15-minute diagnostic test for Histoplasmosis, aiming to reduce wait times and improve the accuracy of disease diagnosis.

Notable figures affiliated with OIDx include leading experts in medical diagnostics and infectious diseases, although specific names are not provided. The company has garnered attention from key investors in the healthcare sector, supporting its innovative approach to rapid diagnostics. OIDx's significant achievements include the development of their 15-minute Histoplasmosis test, which has had a substantial impact on patient care by providing timely and accurate results. Overall, OIDx's contributions are advancing the field of medical diagnostics, particularly in the timely detection and treatment of emerging diseases.

Optimum Imaging Diagnostics - Quick Facts

When was Optimum Imaging Diagnostics founded?

Optimum Imaging Diagnostics was founded in 2015.

Where is Optimum Imaging Diagnostics' headquarters located?

Optimum Imaging Diagnostics' headquarters is located in Scarborough, ME, US.

When was Optimum Imaging Diagnostics' last funding round?

Optimum Imaging Diagnostics' most recent funding round was for $175k (USD) in January 2020.

How much has Optimum Imaging Diagnostics raised to-date?

As of Jan 1, 2020, Optimum Imaging Diagnostics has raised a total of $175k (USD).

How many employees does Optimum Imaging Diagnostics have?

Optimum Imaging Diagnostics has 30 employees as of Feb 4, 2024.

Optimum Imaging Diagnostics - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Medical Tests
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities